Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.
Explore this paper's citation graph
Summary
Myeloid-related protein 8/14 may be a useful biomarker of platelet and inflammatory disease activity in atherothrombosis and may serve as a novel target for therapeutic intervention.
- Type
- article
- Published
- 2008-01-01
- Cited by
- 181
- References
- 24
- Access
- Open access
- OpenAlex
- https://openalex.org/W2039493826
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:5682832
Keywords
Medicine, Myocardial infarction, Pravastatin, Internal medicine, Atorvastatin
References
- Widespread coronary inflammation in unstable angina.
- Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice.
- S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity
- Molecular bases of the acute coronary syndromes.
- Soluble CD40L: Risk Prediction After Acute Coronary Syndromes
- Intracellular and extracellular roles of S100 proteins
- RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
- The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.
- Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin.
- Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
- C-reactive protein levels and outcomes after statin therapy.
- Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets.
- MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.
- Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events
- Signaling mechanisms and the activation of leukocyte integrins
- Inflammation and thrombosis: the clot thickens.
- Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.
- [Pathophysiology of coronary artery disease].
Cited by
- Myeloid-Related Protein Activity in Rheumatoid Arthritis
- Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain
- The influence of low-grade inflammation on platelets in patients with stable coronary artery disease
- Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis
- Kardiale Biomarker bei Myokardinfarkt und Herzinsuffizienz // Use of Cardiac Biomarkers for the Diagnosis of Myocardial Infarction and Heart Failure.
- S100/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis
- Inflammation in Atherosclerosis: From Pathophysiology to Practice
- S100A9—clot not, bleed not
- MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men
- Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease
- Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
- What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease?
- The distribution and expression of S100A8 and S100A9 in gingival epithelium of mice.
- Platelet mRNA: the meaning behind the message
- Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin.
- Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients.
- S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic Cells: Implications for Atherosclerosis and Adipose Tissue Inflammation
- S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease.
- Genomic and Proteomic Applications in Diagnosis of Platelet Disorders and Classification
- Neue Biomarker im akuten Koronarsyndrom
Related papers
- Effect of pravastatin and atorvastatin on serum C-reactive protein in patients with unstable angina
- Effect of atorvastatin and pravastatin on serum C-reactive protein.
- Effect of Changing from Pravastatin to Atorvastatin on Serum Cholesterol Levels
- Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia.
- Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
- Factors Associated With Normal Flow (TIMI 3) After Thrombolysis With Streptokinase in ST-Elevation Myocardial Infarction: A Prospective Observational Study
- Atorvastatin is more effective than pravastatin in preventing recurrent cardiac events
- Effects of atorvastatin on lipid profile modification in patients with dyslipoproteinemia
- Early behavior of biochemical markers in patients with thrombolysis in myocardial infarction grade 2 flow in the infarct artery as opposed to other flow grades after intravenous thrombolysis for acute myocardial infarction. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
- Significance of thrombolysis in myocardial infarction (TIMI) grade 2 flow early after thrombolysis followed by immediate percutaneous coronary intervention in patients with acute myocardial infarction.